It might interest some Florida women to hear that C.R. Bard Inc., a corporation based out of New Jersey, recently agreed to settle hundreds of lawsuits alleging that the company’s vaginal-mesh implants inflicted damage on the bodies of women who used them. According to several claimants, the implants erode over time and cause an assortment of serious complications, including but not limited to organ damage, bleeding and infection.
Authorities reported that the cost to Bard will be approximately $43,000 per lawsuit. A West Virginia federal judge had instructed Bard to make trial preparations for the cascade of lawsuits, reportedly 500 in total. Claimants in these lawsuits have depicted the harm done to them by the vaginal-mesh implants, many claiming they suffered perpetual discomfort and pain during sexual intercourse among several other afflictions.
Another manufacturer of the implants, based out of Dublin, Ireland, recently agreed to pay $1.3 billion in settlements stemming from their vaginal-mesh devices. The device is used to treat incontinence as well as pelvic organ prolapse, and tens of thousands of American women have had these devices implanted in their bodies, reportedly. In 2010 alone, U.S. doctors implanted some 70,000 vaginal-mesh devices in women, authorities said. Due to the multitude of complaints filed in connection with this medical product, the U.S. Food and Drug Administration has ordered several manufacturers, including Bard, to review the complication rates associated with vaginal-mesh implants.
As these lawsuits brought against Bard exemplify, manufacturers of defective medical devices may be subject to civil action. People who suffer injuries or illnesses on account of faulty medical equipment may be entitled to financial restitution in civil court. By retaining a personal injury attorney and filing suit, victims of defective products may be awarded compensation for medical bills, the costs related to long-term treatment and other pecuniary damages directly related to their injuries.
Source: Bloomberg Business, “Bard Said to Pay $21 Million in First Big Vaginal-Mesh Accord“, Jef Feeley, October 08, 2014